发明名称 |
COMBINED USE OF (+)-1,4-DIHYDRO-7-[(3S,4S)-3-METHOXY-4-(METHYLAMINO)-1-PYRROLIDINYL]-4-OXO-1-(2-THIAZOLYL)-1,8-NAPHTHYRIDINE-3-CARBOXYLIC ACID |
摘要 |
PROBLEM TO BE SOLVED: To provide a therapeutic method for acute myeloid leukemia.SOLUTION: The invention provides a therapeutic method for acute myeloid leukemia comprising intravenously administering arabinocytidine (4-amino 1-β-D-arabinofuranosyl 2(1H)-pyrimidinone) in combination with (+)-1,4-dihydro-7-[(3S,4S)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid represented by the following formula.SELECTED DRAWING: None |
申请公布号 |
JP2016053070(A) |
申请公布日期 |
2016.04.14 |
申请号 |
JP20150219880 |
申请日期 |
2015.11.09 |
申请人 |
SUNESIS PHARMACEUTICALS INC |
发明人 |
ADELMAN DANIEL C;SILVERMAN JEFFREY A;MICHELSON GLENN;SCATENA CAROLINE DARNE |
分类号 |
A61K31/4375;A61K31/7068;A61P35/02;A61P43/00 |
主分类号 |
A61K31/4375 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|